ミズホメディーの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/25 | 3,340 | 3,360 | 3,310 | 3,320 | -15 | -0.4% | 26,900 |
| 2024/04/24 | 3,320 | 3,335 | 3,300 | 3,335 | +30 | +0.9% | 22,900 |
| 2024/04/23 | 3,310 | 3,320 | 3,290 | 3,305 | -5 | -0.2% | 16,900 |
| 2024/04/22 | 3,255 | 3,310 | 3,255 | 3,310 | +70 | +2.2% | 15,900 |
| 2024/04/19 | 3,275 | 3,275 | 3,200 | 3,240 | -30 | -0.9% | 43,900 |
| 2024/04/18 | 3,275 | 3,300 | 3,270 | 3,270 | -5 | -0.2% | 20,600 |
| 2024/04/17 | 3,330 | 3,330 | 3,275 | 3,275 | -45 | -1.4% | 38,100 |
| 2024/04/16 | 3,365 | 3,365 | 3,320 | 3,320 | -50 | -1.5% | 29,200 |
| 2024/04/15 | 3,365 | 3,380 | 3,355 | 3,370 | -15 | -0.4% | 18,200 |
| 2024/04/12 | 3,385 | 3,400 | 3,360 | 3,385 | ±0 | ±0% | 19,000 |
| 2024/04/11 | 3,400 | 3,410 | 3,380 | 3,385 | -35 | -1% | 23,300 |
| 2024/04/10 | 3,405 | 3,445 | 3,390 | 3,420 | +20 | +0.6% | 49,800 |
| 2024/04/09 | 3,380 | 3,400 | 3,360 | 3,400 | +25 | +0.7% | 45,800 |
| 2024/04/08 | 3,360 | 3,390 | 3,340 | 3,375 | +25 | +0.7% | 44,400 |
| 2024/04/05 | 3,325 | 3,350 | 3,305 | 3,350 | +20 | +0.6% | 28,200 |
| 2024/04/04 | 3,340 | 3,350 | 3,310 | 3,330 | -10 | -0.3% | 51,100 |
| 2024/04/03 | 3,310 | 3,370 | 3,305 | 3,340 | +45 | +1.4% | 47,100 |
| 2024/04/02 | 3,345 | 3,345 | 3,290 | 3,295 | -50 | -1.5% | 44,700 |
| 2024/04/01 | 3,365 | 3,370 | 3,325 | 3,345 | -20 | -0.6% | 60,100 |
| 2024/03/29 | 3,275 | 3,365 | 3,270 | 3,365 | +110 | +3.4% | 78,600 |
| 2024/03/28 | 3,235 | 3,280 | 3,230 | 3,255 | +20 | +0.6% | 28,600 |
| 2024/03/27 | 3,235 | 3,305 | 3,235 | 3,235 | +15 | +0.5% | 75,800 |
| 2024/03/26 | 3,235 | 3,235 | 3,195 | 3,220 | -10 | -0.3% | 57,700 |
| 2024/03/25 | 3,250 | 3,270 | 3,230 | 3,230 | -20 | -0.6% | 37,100 |
| 2024/03/22 | 3,245 | 3,270 | 3,205 | 3,250 | +20 | +0.6% | 74,300 |
| 2024/03/21 | 3,270 | 3,270 | 3,225 | 3,230 | -45 | -1.4% | 83,500 |
| 2024/03/19 | 3,275 | 3,275 | 3,245 | 3,275 | ±0 | ±0% | 30,700 |
| 2024/03/18 | 3,270 | 3,280 | 3,255 | 3,275 | +15 | +0.5% | 35,200 |
| 2024/03/15 | 3,285 | 3,290 | 3,225 | 3,260 | -30 | -0.9% | 82,900 |
| 2024/03/14 | 3,285 | 3,310 | 3,260 | 3,290 | +30 | +0.9% | 37,700 |
| 2024/03/13 | 3,325 | 3,330 | 3,245 | 3,260 | -60 | -1.8% | 40,400 |
| 2024/03/12 | 3,265 | 3,320 | 3,250 | 3,320 | +50 | +1.5% | 43,700 |
| 2024/03/11 | 3,295 | 3,300 | 3,250 | 3,270 | -25 | -0.8% | 31,000 |
| 2024/03/08 | 3,245 | 3,325 | 3,245 | 3,295 | +45 | +1.4% | 55,700 |
| 2024/03/07 | 3,285 | 3,300 | 3,250 | 3,250 | -30 | -0.9% | 40,000 |
| 2024/03/06 | 3,280 | 3,305 | 3,275 | 3,280 | -10 | -0.3% | 40,400 |
| 2024/03/05 | 3,345 | 3,365 | 3,280 | 3,290 | -55 | -1.6% | 51,700 |
| 2024/03/04 | 3,340 | 3,375 | 3,325 | 3,345 | +5 | +0.1% | 46,300 |
| 2024/03/01 | 3,355 | 3,385 | 3,330 | 3,340 | +10 | +0.3% | 47,500 |
| 2024/02/29 | 3,300 | 3,345 | 3,255 | 3,330 | +25 | +0.8% | 52,400 |
| 2024/02/28 | 3,255 | 3,330 | 3,255 | 3,305 | +65 | +2% | 64,700 |
| 2024/02/27 | 3,320 | 3,320 | 3,240 | 3,240 | -105 | -3.1% | 142,100 |
| 2024/02/26 | 3,355 | 3,375 | 3,325 | 3,345 | ±0 | ±0% | 48,600 |
| 2024/02/22 | 3,375 | 3,385 | 3,335 | 3,345 | -30 | -0.9% | 58,000 |
| 2024/02/21 | 3,400 | 3,405 | 3,360 | 3,375 | -30 | -0.9% | 37,100 |
| 2024/02/20 | 3,450 | 3,470 | 3,385 | 3,405 | -40 | -1.2% | 58,100 |
| 2024/02/19 | 3,380 | 3,450 | 3,380 | 3,445 | +70 | +2.1% | 46,100 |
| 2024/02/16 | 3,370 | 3,420 | 3,340 | 3,375 | +30 | +0.9% | 80,400 |
| 2024/02/15 | 3,400 | 3,430 | 3,315 | 3,345 | -105 | -3% | 163,000 |
| 2024/02/14 | 3,565 | 3,620 | 3,435 | 3,450 | -130 | -3.6% | 171,400 |
151～
200
件表示中 / 2191件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ミズホメディ | 156,900円 | -5.1% | -21.2% | 5.10% | 9.91倍 | 1.89倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| ハートシード | 150,300円 | +154.1% | - | 0.00% | - | 7.36倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ダイト | 212,900円 | +4.5% | -10.8% | 3.29% | 14.16倍 | 0.63倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| 扶桑薬 | 255,500円 | +8.3% | +98.1% | 3.21% | 8.39倍 | 0.58倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| セルソース | 102,500円 | -3.0% | -55.9% | 0.49% | 48.69倍 | 3.36倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
